Weight Loss
Provider-guided GLP-1 and GLP-1/GIP therapy designed to support appetite regulation and metabolic health as part of a structured weight management program.
As Low As $209
Secure online intake. Takes about 5 minutes.
GLP-1 and GLP-1/GIP therapies are prescription medications used to support appetite regulation and metabolic function as part of a structured weight management program. These therapies work with hormone pathways involved in hunger signaling and feelings of fullness.
At Alorah Wellness, compounded GLP-1 medications containing semaglutide or tirzepatide may be prescribed through a secure telehealth process following review by a licensed provider. Your provider evaluates your medical history, symptoms, and relevant clinical information to determine whether treatment may be appropriate.
If prescribed, your provider will oversee your care and make adjustments when medically appropriate.
Weight Loss
GLP-1 therapy designed to support appetite control and metabolic balance through structured telehealth care.
Weight Loss
Dual-agonist GLP-1/GIP therapy supporting appetite regulation and structured medical weight management.
These therapies interact with receptors involved in appetite signaling and metabolic regulation. GLP-1 therapies target one pathway, while GLP-1/GIP therapies work on two pathways involved in metabolic signaling.
Treatment decisions, dosing, and adjustments are determined by a licensed provider based on your medical evaluation and ongoing care needs.
GLP-1 and GLP-1/GIP programs may be appropriate for individuals seeking medical support for weight management when clinically indicated.
Eligibility is determined by a licensed provider following review of your health history and any required clinical information.
Transparent monthly pricing. No hidden fees.
A structured telehealth process designed around your goals.
Share your health history and what you're trying to improve.
A licensed provider evaluates your intake and recommends the right path.
If appropriate, your plan starts with delivery and ongoing monitoring.
You will complete a secure online intake form that is reviewed by a licensed provider. The provider evaluates your health history and determines whether treatment may be appropriate. If prescribed, your care will continue to be monitored through the program.
Lab requirements depend on your medical history and provider assessment. Your provider will determine whether testing is necessary as part of your evaluation.
Your provider may prescribe a compounded GLP-1 or GLP-1/GIP medication containing semaglutide or tirzepatide. The specific therapy and dosing are determined based on your medical evaluation, safety considerations, and treatment goals.
GLP-1 medications are prescription treatments and are not appropriate for everyone. Eligibility is determined by a licensed provider following review of your medical history.
Do not use GLP-1 therapy if you or a family member have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
In animal studies, certain GLP-1 medications caused thyroid C-cell tumors. It is unknown whether this risk applies to humans. Contact your provider if you experience neck swelling, hoarseness, trouble swallowing, or shortness of breath.
GLP-1 therapy may cause gastrointestinal side effects including nausea, vomiting, diarrhea, constipation, or abdominal pain. More serious risks may include pancreatitis, gallbladder disease, hypoglycemia (especially in patients using insulin or certain diabetes medications), kidney complications, increased heart rate, or allergic reactions.
This is not a complete list of risks.
Medication instructions and administration guidance are provided with your prescription. Always follow the directions provided by your prescribing provider and pharmacy.
Medication packaging, labeling, and appearance may differ from images displayed on this website. The medication you receive will reflect what has been prescribed and dispensed by the pharmacy.
The Food and Drug Administration has not evaluated these statements. The FDA neither approves nor reviews compounded products for safety, effectiveness, or quality. This product is not intended to diagnose, treat, cure, or prevent any disease.
All medications listed are prescription-only products and require a consultation with a licensed healthcare provider. Always consult with a professional before starting a new treatment.
Refund Policy for pre-paid 12 & 24 week GLP Programs:
For our 12-week and 24-week GLP programs, we offer significant discounts for services and medications purchased upfront. Due to this discounted rate:
Contact Support
If you have questions regarding your specific plan or need assistance with a cancellation, our team is here to help.
Email: ps@agiletelehealth.com
View Full Important Safety InformationStructured telehealth care with licensed provider oversight.
Start IntakeSecure intake. Takes about 5 minutes.